Older patients with PAH who were at least 55 years old showed significantly smaller improvements in 6-minute walk distance.
Ralinepag reduced the risk of clinical worsening in patients with pulmonary arterial hypertension by 55%, according to recent study results.
New ACC/AHA guidelines provide updated recommendations for dyslipidemia management, focusing on atherogenic lipoproteins and risk assessment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results